Dyskeratosis congenita: Molecular insights into telomerase function, ageing and cancer

Expert Reviews in Molecular Medicine

Volumn 6, Issue 26, 2004, Pages 1-23

  Marrone, Anna ^a   Dokal, Inderjeet ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Aplastic anaemia; Dyskeratosis congenita; Dyskerin; Telomerase; Telomere; TERC; TERT

Indexed keywords

DYSKERIN; RIBOSOME RNA; RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TELOMERASE;

AUTOSOMAL DOMINANT INHERITANCE; BONE MARROW DEPRESSION; CANCER; DISEASE SEVERITY; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GENETIC DISORDER; HUMAN; PATHOPHYSIOLOGY; PREMATURE AGING; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; SKIN DISEASE; TELOMERE; X CHROMOSOME RECESSIVE INHERITANCE;

AGING; AGING, PREMATURE; BONE MARROW; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DYSKERATOSIS CONGENITA; FEMALE; GENETIC HETEROGENEITY; HUMANS; MALE; MUTATION; NEOPLASMS; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; RIBONUCLEOPROTEINS, SMALL NUCLEOLAR; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL; TELOMERASE; TELOMERE;

EID: 18044399024     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399404008671     Document Type: Review

References (136)

1. Zinsser, F. (1906) Atrophia cutis reticularis cum pigmentatione, dystrophia unguium et leukoplakia oris (poikilodermia atrophicans vascularis Jacobi). Ikonogr Derm (Kyoto) 5, 219-223
2. Engman, M. (1926) A unique case of reticular pigmentation of the skin with atrophy. Arch Derm Syph Suppl 13, 685-687
3. Cole, H., Rauschkolb, J. and Toomey, J. (1930) Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris. Arch Derm Syph 21, 71-95
4. Drachtman, R.A. and Alter, B.P. (1995) Dyskeratosis congenita. Dermatol Clin 13, 33-39,
5. Dokal, I. (1996) Dyskeratosis congenita: an inherited bone marrow failure syndrome. Br J Haematol 92, 775-779,
6. Knight, S. et al. (1998) Dyskeratosis Congenita (DC) Registry: identification of new features of DC. Br J Haematol 103, 990-996,
7. Dokal, I. (2000) Dyskeratosis congenita in all its forms. Br J Haematol 110, 768-779,
8. Milgrom, H., Stoll, H.L., Jr. and Crissey, J.T. (1964) Dyskeratosis Congenita. A Case with New Features. Arch Dermatol 89, 345-349,
9. Dokal, I. (2001) Dyskeratosis congenita. A disease of premature ageing. Lancet 358 Suppl, S27,
10. Vulliamy, T. et al. (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432-435,
11. Solder, B. et al. (1998) Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects. A review of the literature. Clin Pediatr (Phila) 37, 521-530,
12. Marrone, A. and Mason, P.J. (2003) Dyskeratosis congenita. Cell Mol Life Sci 60, 507-517,
13. Walne, A.J. and Dokal, I. Telomerase dysfunction and dyskeratosis congenita. Cytotechnology (in press)
14. Heiss, N.S. et al. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19, 32-38,
15. Jiang, W. et al. (1993) An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules. Mol Cell Biol 13, 4884-4893,
16. Meier, U.T. and Blobel, G. (1994) NAP57, a mammalian nucleolar protein with a putative homolog in yeast and bacteria. J Cell Biol 127, 1505-1514,
17. Ni, J., Tien, A.L. and Fournier, M.J. (1997) Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89, 565-573,
18. Youssoufian, H., Gharibyan, V. and Qatanani, M. (1999) Analysis of epitope-tagged forms of the dyskeratosis congenital protein (dyskerin): identification of a nuclear localization signal. Blood Cells Mol Dis 25, 305-309,
19. Filipowicz, W. and Pogacic, V. (2002) Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol 14, 319-327,
20. Lafontaine, D.L. et al. (1998) The box H + ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev 12, 527-537,
21. Zebarjadian, Y. et al. (1999) Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA. Mol Cell Biol 19, 7461-7472,
22. Blackburn, E.H. (1991) Structure and function of telomeres. Nature 350, 569-573,
23. Greider, C.W. (1996) Telomere length regulation. Annu Rev Biochem 65, 337-365,
24. Keith, W.N. et al. (2002) Telomerase-directed molecular therapeutics. Expert Rev Mol Med 2002, 1-25,
25. Tollervey, D. and Kiss, T. (1997) Function and synthesis of small nucleolar RNAs. Curr Opin Cell Biol 9, 337-342,
26. Luzzatto, L. and Karadimitris, A. (1998) Dyskeratosis and ribosomal rebellion. Nat Genet 19, 6-7,
27. Mitchell, J.R., Wood, E. and Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555,
28. Vulliamy, T.J. et al. (2001) Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 27, 353-357,
29. Montanaro, L. et al. (2002) Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines. J Invest Dermatol 118, 193-198,
30. Rhodes, D. et al. (2002) Telomere architecture. EMBO Rep 3, 1139-1145,
31. Feng, J. et al. (1995) The RNA component of human telomerase. Science 269, 1236-1241,
32. Lingner, J. et al. (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561-567,
33. Meyerson, M. et al. (1997) hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90, 785-795,
34. Nakamura, T.M. et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959,
35. Blackburn, E.H. et al. (1989) Recognition and elongation of telomeres by telomerase. Genome 31, 553-560,
36. Shippen-Lentz, D. and Blackburn, E.H. (1990) Functional evidence for an RNA template in telomerase. Science 247, 546-552,
37. Autexier, C. and Greider, C.W. (1994) Functional reconstitution of wild-type and mutant Tetrahymena telomerase. Genes Dev 8, 563-575,
38. Masutomi, K. et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114, 241-253,
39. Ben-Porath, I. and Weinberg, R.A. (2004) When cells get stressed: an integrative view of cellular senescence. J Clin Invest 113, 8-13,
40. Harley, C.B., Futcher, A.B. and Greider, C.W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460,
41. Colgin, L.M. and Reddel, R.R. (1999) Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 9, 97-103,
42. Kim, N.W. et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015,
43. Wright, W.E. et al. (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18, 173-179,
44. Broccoli, D., Young, J.W. and de Lange, T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 92, 9082-9086,
45. Counter, C.M. et al. (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85, 2315-2320,
46. Weng, N.P. et al. (1996) Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 183, 2471-2479,
47. Chen, J.L., Blasco, M.A. and Greider, C.W. (2000) Secondary structure of vertebrate telomerase RNA. Cell 100, 503-514,
48. Chen, J.L. and Greider, C.W. (2004) Telomerase RNA structure and function: implications for dyskeratosis congenita. Trends Biochem Sci 29, 183-192,
49. Martin-Rivera, L. and Blasco, M.A. (2001) Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J Biol Chem 276, 5856-5865,
50. Theimer, C.A. et al. (2003) Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc Natl Acad Sci U S A 100, 449-454,
51. Comolli, L.R. et al. (2002) A molecular switch underlies a human telomerase disease. Proc Natl Acad Sci U S A 99, 16998-17003,
52. Leeper, T., Leulliot, N. and Varani, G. (2003) The solution structure of an essential stem-loop of human telomerase RNA. Nucleic Acids Res 31, 2614-2621,
53. Vulliamy, T. et al. (2002) Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359, 2168-2170,
54. Fogarty, P.F. et al. (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 362, 1628-1630,
55. Yamaguchi, H. et al. (2003) Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102, 916-918,
56. Vulliamy, T. et al. (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36, 447-449,
57. Chen, J.L. and Greider, C.W. (2003) Template boundary definition in mammalian telomerase. Genes Dev 17, 2747-2752,
58. Ly, H., Blackburn, E.H. and Parslow, T.G. (2003) Comprehensive structure-function analysis of the core domain of human telomerase RNA. Mol Cell Biol 23, 6849-6856,
59. Fu, D. and Collins, K. (2003) Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol Cell 11, 1361-1372,
60. Ren, X. et al. (2003) Identification of a new RNA.RNA interaction site for human telomerase RNA (hTR): structural implications for hTR accumulation and a dyskeratosis congenita point mutation. Nucleic Acids Res 31, 6509-6515,
61. Theimer, C.A., Finger, L.D. and Feigon, J. (2003) YNMG tetraloop formation by a dyskeratosis congenita mutation in human telomerase RNA. Rna 9, 1446-1455,
62. Marrone, A. et al. (2004) Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency. Blood, 104, 3936-3942,
63. Hathcock, K.S. et al. (2002) Haploinsufficiency of mTR results in defects in telomere elongation. Proc Natl Acad Sci U S A 99, 3591-3596,
64. Chiang, Y.J. et al. (2004) Expression of telomerase RNA template, but not telomerase reverse transcriptase, is limiting for telomere length maintenance in vivo. Mol Cell Biol 24, 7024-7031,
65. Blasco, M.A. et al. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34,
66. Lee, H.W. et al. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574,
67. Rudolph, K.L. et al. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712,
68. Zhu, L. et al. (1998) Telomere length regulation in mice is linked to a novel chromosome locus. Proc Natl Acad Sci U S A 95, 8648-8653,
69. Keith, W.N. et al. (2004) A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disord 4, 3,
70. Zhao, J. et al. (2003) Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Lett 536, 111-119,
71. Kinoshita, T. and Inoue, N. (2002) Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria. Int J Hematol 75, 117-122,
72. Bessler, M., Schaefer, A. and Keller, P. (2001) Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology. Transfus Med Rev 15, 255-267,
73. Autexier, C. et al. (1996) Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. Embo J 15, 5928-5935,
74. Tesmer, V.M. et al. (1999) Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol 19, 6207-6216,
75. Beattie, T.L. et al. (2000) Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol Biol Cell 11, 3329-3340,
76. Mitchell, J.R. and Collins, K. (2000) Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol Cell 6, 361-371,
77. Bachand, F. and Autexier, C. (2001) Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol Cell Biol 21, 1888-1897,
78. Antal, M. et al. (2002) Analysis of the structure of human telomerase RNA in vivo. Nucleic Acids Res 30, 912-920,
79. Chen, J.L., Opperman, K.K. and Greider, C.W. (2002) A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res 30, 592-597,
80. Ueda, C.T. and Roberts, R.W. (2004) Analysis of a long-range interaction between conserved domains of human telomerase RNA. Rna 10, 139-147,
81. Keppler, B.R. and Jarstfer, M.B. (2004) Inhibition of telomerase activity by preventing proper assemblage. Biochemistry 43, 334-343,
82. Prescott, J. and Blackburn, E.H. (1997) Functionally interacting telomerase RNAs in the yeast telomerase complex. Genes Dev 11, 2790-2800,
83. Wenz, C. et al. (2001) Human telomerase contains two cooperating telomerase RNA molecules. Embo J 20, 3526-3534,
84. Wang, L., Dean, S.R. and Shippen, D.E. (2002) Oligomerization of the telomerase reverse transcriptase from Euplotes crassus. Nucleic Acids Res 30, 4032-4039,
85. Mitchell, J.R., Cheng, J. and Collins, K. (1999) A box H/ ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol 19, 567-576,
86. Dragon, F., Pogacic, V. and Filipowicz, W. (2000) In vitro assembly of human H/ ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol 20, 3037-3048,
87. Lukowiak, A.A. et al. (2001) The snoRNA domain of vertebrate telomerase RNA functions to localize the RNA within the nucleus. Rna 7, 1833-1844,
88. Bryan, T.M. et al. (1997) The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 6, 921-926,
89. Reddel, R.R. et al. (2001) Alternative lengthening of telomeres in human cells. Radiat Res 155, 194-200,
90. Bailey, S.M., Brenneman, M.A. and Goodwin, E.H. (2004) Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res 32, 3743-3751,
91. Londono-Vallejo, J.A. et al. (2004) Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64, 2324-2327,
92. Wilson, D.B. et al. (2003) Human telomerase RNA mutations and bone marrow failure. Lancet 361, 1993-1994,
93. Bessler, M., Wilson, D.B. and Mason, P.J. (2004) Dyskeratosis congenita and telomerase. Curr Opin Pediatr 16, 23-28,
94. Weinstein, B.S. and Ciszek, D. (2002) The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp Gerontol 37, 615-627,
95. Sharpless, N.E. and DePinho, R.A. (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113, 160-168,
96. Pelicci, P.G. (2004) Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J Clin Invest 113, 4-7,
97. He, J. et al. (2002) Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 21, 7740-7744,
98. Ruggero, D. et al. (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259-262,
99. Yui, J., Chiu, C.P. and Lansdorp, P.M. (1998) Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 91, 3255-3262,
100. Allsopp, R.C. and Weissman, I.L. (2002) Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene 21, 3270-3273,
101. Anantharaman, V., Koonin, E.V. and Aravind, L. (2002) Comparative genomics and evolution of proteins involved in RNA metabolism. Nucleic Acids Res 30, 1427-1464,
102. Mushegian, A.R. and Koonin, E.V. (1996) A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc Natl Acad Sci U S A 93, 10268-10273,
103. Ferre-D'Amare, A.R. (2003) RNA-modifying enzymes. Curr Opin Struct Biol 13, 49-55,
104. Curran, J.F. (1998) Modified nucleosides in translation. In Modification and Editing of RNA: the Alteration of RNA Structure and Function (Grosjean, H. and Benne, R., eds), pp. 493-516, ASM Press, Washington, D.C.
105. Kiss, T. (2001) Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. Embo J 20, 3617-3622,
106. Aravind, L. and Koonin, E.V. (1999) Novel predicted RNA-binding domains associated with the translation machinery. J Mol Evol 48, 291-302,
107. Ramamurthy, V. et al. (1999) Critical aspartic acid residues in pseudouridine synthases. J Biol Chem 274, 22225-22230,
108. Meier, U.T. (2003) Dissecting dyskeratosis. Nat Genet 33, 116-117,
109. Ball, S.E. et al. (1998) Progressive telomere shortening in aplastic anemia. Blood 91, 3582-3592,
110. Brummendorf, T.H. et al. (2001) Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann N Y Acad Sci 938, 293-303; discussion 303-304,
111. Dokal, I. and Vulliamy, T. (2003) Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 17, 217-225,
112. Knight, S.W. et al. (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107, 335-339,
113. Qasim, W., Gaspar, H.B. and Thrasher, A.J. (2004) Gene therapy for severe combined immune deficiency. Expert Rev Mol Med 2004, 1-15,
114. Etheridge, K.T. et al. (2002) The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277, 24764-24770,
115. Wong, J.M., Kusdra, L. and Collins, K. (2002) Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4, 731-736,
116. Yang, Y. et al. (2002) Nucleolar localization of hTERT protein is associated with telomerase function. Exp Cell Res 277, 201-209,
117. Zhu, Y. et al. (2004) Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol Biol Cell 15, 81-90,
118. Kiss, T. (2002) Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109, 145-148,
119. Terns, M.P. and Terns, R.M. (2002) Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin. Gene Expr 10, 17-39,
120. Teixeira, M.T. et al. (2002) Intracellular trafficking of yeast telomerase components. EMBO Rep 3, 652-659,
121. Lin, S.Y. and Elledge, S.J. (2003) Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113, 881-889,
122. Knight, S.W. et al. (2001) Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet 108, 299-303,
123. Knight, S.W. et al. (1999) X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 65, 50-58,
124. Safa, W.F., Lestringant, G.G. and Frossard, P.M. (2001) X-linked dyskeratosis congenita: restrictive pulmonary disease and a novel mutation. Thorax 56, 891-894,
125. Vulliamy, T. et al. (2004) The genetic and phenotypic diversity of dyskeratosis congenita. American Society of Hematology 104, 52 (Abstract 169)
126. Wong, J.M. et al. (2004) Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita. Hum Genet 115, 448-455,
127. Cossu, F. et al. (2002) A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK-SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haematol 119, 765-768,
128. Heiss, N.S. et al. (2001) One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC). Genet Couns 12, 129-136,
129. Knight, S.W. et al. (1999) Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 107, 335-339,
130. Sznajer, Y. et al. (2003) Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr 162, 863-867,
131. Rostamiani, K. et al. (1999) Novel missense mutations in the DKC1 gene in patients with dyskeratosis congenita. American Journal of Human Genetics 65, A488
132. Yaghmai, R. et al. (2000) Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome. J Pediatr 136, 390-393,
133. Lin, J.H. et al. (2002) DKC1 gene mutation in a Taiwanese kindred with X-linked dyskeratosis congenita. Kaohsiung J Med Sci 18, 573-577,
134. Viprakasit, V. and Tanphaichitr, V.S. (2001) Recurrent A353V mutation in a Thai family with X-linked dyskeratosis congenita. Haematologica 86, 871-872,
135. Hiramatsu, H. et al. (2002) A novel missense mutation in the DKC1 gene in a Japanese family with X-linked dyskeratosis congenita. Pediatr Hematol Oncol 19, 413-419,
136. Ding, Y.G. et al. (2004) Identification of a novel mutation and a de novo mutation in DKC1 in two Chinese pedigrees with Dyskeratosis congenita. J Invest Dermatol 123, 470-473,